Your browser doesn't support javascript.
loading
Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: The TYREE study.
LaForce, Craig; Chipps, Bradley E; Albers, Frank C; Reilly, Laurence; Johnsson, Eva; Andrews, Helen; Cappelletti, Christy; Maes, Andrea; Papi, Alberto.
Afiliação
  • LaForce C; North Carolina Clinical Research, Raleigh, North Carolina. Electronic address: CLaForce@nccr.com.
  • Chipps BE; Capital Allergy & Respiratory Disease Center, Sacramento, California.
  • Albers FC; Avillion US Inc, Northbrook, Illinois.
  • Reilly L; Acumen Life Science Consulting, London, United Kingdom.
  • Johnsson E; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Andrews H; Avillion US Inc, Northbrook, Illinois.
  • Cappelletti C; BioPharmaceuticals R&D, AstraZeneca, Durham, North Carolina.
  • Maes A; BioPharmaceuticals R&D, AstraZeneca, Wilmington, Delaware; Insmed Inc, Bridgewater, New Jersey.
  • Papi A; Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Ann Allergy Asthma Immunol ; 128(2): 169-177, 2022 02.
Article em En | MEDLINE | ID: mdl-34699967
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Albuterol Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Albuterol Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article